van Gysen KL, Kneebone AB, Guo L, Vaux KJ, Lazzaro EM, Eade TN. Health-related quality of life using intensity-modulated radiation therapy for post-prostatectomy radiotherapy. J Med Imaging Radiat Oncol. 2013 Feb;57(1):89-96

Ng JA, Booth JT, Poulsen PR, Fledelius W, Worm ES, Eade T, Hegi F, Kneebone A, Kuncic Z, Keall PJ.  Kilovoltage intrafraction monitoring for prostate intensity modulated arc therapy: first clinical results. Int J Radiat Oncol Biol Phys. 2012

Eade T. Better late than never. J Med Imaging Radiat Oncol. 2012 Jun;56(3):245-6.

Herschtal A, Foroudi F, Greer PB, Eade TN, Hindson BR, Kron T.  Finding the optimal statistical model to describe target motion during radiotherapy delivery–a Bayesian approach. Phys Med Biol. 2012 May 7;57(9):2743-55

Eade T, Guo L, Forde E, Vaux K, Vass J, Hunt P, Kneebone A.

Image Guided Dose Escalated IMRT for Prostate Cancer: Treating to Doses Beyond 78Gy. BJUI (Accepted Jun 2011)


Kench JG, Clouston DR, Delprado W, Eade T, Ellis D, Horvath LG, et al. Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens. Pathology. 2011 Aug;43(5):410-9.


Johnston ML, Vial P, Wiltshire KL, Bell LJ, Blome S, Kerestes Z, Morgan GW, O’Driscoll D, Shakespeare TP, Eade TN.  Daily Online Bony Correction is Required for Prostate Patients Without Fiducial Markers or Soft-tissue Imaging. Clin Oncol (R Coll Radiol). 2011 Sep;23(7):454-9.


Johnston M, Clifford S, Bromley R, Back M, Oliver L, Eade T. Volumetric-modulated Arc Therapy in Head and Neck Radiotherapy: A Planning Comparison using Simultaneous Integrated Boost for Nasopharynx and Oropharynx Carcinoma. Clin Oncol (R Coll Radiol). 2011 Mar 10.


Martin J, Frantzis J, Eade T, Chung, P. Clinician’s guide to prostate IMRT plan assessment and optimization. J Med Imaging Radiat Oncol2010:54:569-75


Sharma NK, Cohen RJ, Eade TN, Buyyounouski MK, Uzzo RG, Li J, Crawford K, Chen DY, McNeeley S, Horwitz EM. An intraoperative real-time sleeved seed technique for permanent prostate brachytherapy. Brachytherapy. 2009 Oct 20


Eade TN, Horwitz EM, Ruth K, Buyyounouski MK, D’Ambrosio DJ, Feigenberg SJ, Chen DY, Pollack A. A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant. Int J Radiat Oncol Biol Phys 2008;71:338-345.


Back M, Oliver L, Bromley R and Eade T. Multicentre quality assurance of intensity-modulated radiotherapy planning: beware the benchmarker. J Med Imaging Radiat Oncol 2008;52:197.


Eade TN, Hanlon AL, Horwitz EM, Buyyounouski MK, Hanks GE, Pollack A.

What dose of external-beam radiation is high enough for prostate cancer? Int J Radiat Oncol Biol Phys 2007;68:682-689.


Eade TN, Al-Saleem T, Horwitz EM, Buyyounouski MK, Chen DY, Pollack A. Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate. Cancer 2007;109:2011-2015.


Berman EL, Eade TN, Shields CL, Shields JA, Ehya H, Feigenberg SJ, Konski AA. Choroidal metastasis from carcinoid tumour: diagnosis by fine-needle biopsy and response to radiotherapy. Australas Radiol 2007;51:398-402.


Berman EL, Eade TN, Brown D, Weaver M, Glass J, Zorman G, Feigenberg SJ. Radiation-induced tumor after stereotactic radiosurgery for an arteriovenous malformation: case report. Neurosurgery 2007;61:E1099; discussion E1099.


Eade TN, Fulham MJ, Constable CJ. Primary malignant peritoneal mesothelioma: appearance on F-18 FDG positron emission tomographic images. Clin Nucl Med 2002;27:924-925.


Eade T, Tan B, Mansberg R, et al. An unusual case of chloroma without marrow involvement demonstrated on Ga-67 scintigraphy. Clin Nucl Med 2002;27:359-360.